Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Reference60 articles.
1. Woelber L, Eulenburg C, Kosse J, Neuser P, Heiss C, Hantschmann P, et al. AGO-CaRE 1 investigators. Predicting the course of disease in recurrent vulvar cancer–a subset analysis of the AGO-CaRE-1 study. Gynecol Oncol. 2019;154(3):571–6. https://doi.org/10.1016/j.ygyno.2019.07.009. (Epub 2019 Jul 17 PMID: 31324454).
2. Oonk MHM, Planchamp F, Baldwin P, Bidzinski M, Brännström M, Landoni F, et al. European society of gynaecological oncology guidelines for the management of patients with vulvar cancer. Int J Gynecol Cancer. 2017;27(4):832–7. https://doi.org/10.1097/IGC.0000000000000975. (PMID: 28441255).
3. Kellas-Ślęczka S, Białas B, Fijałkowski M, Wojcieszek P, Szlag M, Cholewka A, et al. Interstitial high-dose-rate brachytherapy in locally advanced and recurrent vulvar cancer. J Contemp Brachytherapy. 2016;8(1):32–40. https://doi.org/10.5114/jcb.2016.58081. (Epub 2016 Feb 29 PMID: 26985195; PMCID: PMC4793072).
4. Laliscia C, Gadducci A, Montrone S, Tana R, Morganti R, Fabrini MG, et al. Radiotherapy as definitive treatment of patients with primary vulvar carcinoma unfit for surgery and with recurrent vulvar carcinoma after primary radical surgery: results of a retrospective single-center study. Anticancer Res. 2016;36(1):387–91 (PMID: 26722070).
5. Pohar S, Hoffstetter S, Peiffert D, Luporsi E, Pernot M. Effectiveness of brachytherapy in treating carcinoma of the vulva. Int J Radiat Oncol Biol Phys. 1995;32(5):1455–60. https://doi.org/10.1016/0360-3016(95)00109-C. (PMID: 7635788).
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献